Analysis of Clinically Actionable Alterations in Baseline Tumor Versus Plasma Samples in Participants of the TOPAZ-1 Study of Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined